Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Cytiva BioProcess R&D AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 12,787,611 More Arrow 17,011,724 Less Arrow 14,786,287
Financial expenses 0 More Arrow 11,543 More Arrow 13,201
Earnings before taxes 6,021,750 More Arrow 9,901,946 Less Arrow 7,884,369
EBITDA 12,264,229 More Arrow 16,485,575 Less Arrow 14,474,639
Total assets 36,946,293 Less Arrow 35,410,790 Less Arrow 26,555,022
Current assets 14,935,355 Less Arrow 13,172,016 Less Arrow 246,748
Current liabilities 14,240,079 More Arrow 22,878,621 Less Arrow 13,444,433
Equity capital 22,706,214 Less Arrow 11,534,007 Less Arrow 10,665,472
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 61.5% Less Arrow 32.6% More Arrow 40.2%
Turnover per employee
Profit as a percentage of turnover 47.1% More Arrow 58.2% Less Arrow 53.3%
Return on assets (ROA) 16.3% More Arrow 28.0% More Arrow 29.7%
Current ratio 104.9% Less Arrow 57.6% Less Arrow 1.8%
Return on equity (ROE) 26.5% More Arrow 85.9% Less Arrow 73.9%
Change turnover -4,224,113 More Arrow 2,225,437 More Arrow 4,828,259
Change turnover % -25% More Arrow 15% More Arrow 48%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.